MedTrace Logo

A Randomized Sham-controlled Study of Pulmonary Vein Isolation in Symptomatic Atrial Fibrillation

NCT04272762 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2024-03-13

No results posted yet for this study

Summary

This is a double blinded randomised placebo-controlled trial comparing the effects of catheter ablation (Cryoablation) versus a placebo procedure on atrial fibrillation burden, symptoms and quality of life

Conditions

Interventions

PROCEDURE

Cryoablation

Pulmonary vein isolation with cryoablation

PROCEDURE

Placebo

Placebo procedure

Sponsors & Collaborators

  • Eastbourne Cardiology Research Charity Fund

    collaborator UNKNOWN

  • Medtronic

    collaborator INDUSTRY

  • East Sussex Hospitals NHS Trust

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-23
Primary Completion
2024-03-04
Completion
2024-03-04

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04272762 on ClinicalTrials.gov